1. Home
  2. WST vs EL Comparison

WST vs EL Comparison

Compare WST & EL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • EL
  • Stock Information
  • Founded
  • WST 1923
  • EL 1946
  • Country
  • WST United States
  • EL United States
  • Employees
  • WST N/A
  • EL N/A
  • Industry
  • WST Medical/Dental Instruments
  • EL Package Goods/Cosmetics
  • Sector
  • WST Health Care
  • EL Consumer Discretionary
  • Exchange
  • WST Nasdaq
  • EL Nasdaq
  • Market Cap
  • WST 23.2B
  • EL 26.7B
  • IPO Year
  • WST N/A
  • EL 1995
  • Fundamental
  • Price
  • WST $332.77
  • EL $75.08
  • Analyst Decision
  • WST Strong Buy
  • EL Hold
  • Analyst Count
  • WST 5
  • EL 20
  • Target Price
  • WST $437.75
  • EL $89.22
  • AVG Volume (30 Days)
  • WST 494.1K
  • EL 4.4M
  • Earning Date
  • WST 02-13-2025
  • EL 02-04-2025
  • Dividend Yield
  • WST 0.25%
  • EL 1.86%
  • EPS Growth
  • WST N/A
  • EL N/A
  • EPS
  • WST 6.74
  • EL 0.56
  • Revenue
  • WST $2,876,400,000.00
  • EL $15,451,000,000.00
  • Revenue This Year
  • WST N/A
  • EL N/A
  • Revenue Next Year
  • WST $6.08
  • EL $4.01
  • P/E Ratio
  • WST $49.37
  • EL $133.63
  • Revenue Growth
  • WST N/A
  • EL N/A
  • 52 Week Low
  • WST $265.00
  • EL $62.29
  • 52 Week High
  • WST $413.70
  • EL $159.75
  • Technical
  • Relative Strength Index (RSI)
  • WST 58.00
  • EL 46.53
  • Support Level
  • WST $325.33
  • EL $73.89
  • Resistance Level
  • WST $335.53
  • EL $82.11
  • Average True Range (ATR)
  • WST 7.96
  • EL 2.27
  • MACD
  • WST 0.32
  • EL -0.47
  • Stochastic Oscillator
  • WST 78.28
  • EL 14.99

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About EL Estee Lauder Companies Inc. (The)

Estee Lauder is a leader in the global prestige beauty market, participating across skin care (51% of fiscal 2024 sales), makeup (29%), fragrance (16%), and hair care (4%) categories, with top-selling brands such as Estee Lauder, Clinique, M.A.C, La Mer, Jo Malone London, Aveda, Bobbi Brown, and Origins. The firm operates in more than 150 countries, generating 30% of revenue from the Americas, 39% from Europe, the Middle East and Africa (including travel retail), and 31% from Asia-Pacific. Estee Lauder sells its products through department stores, travel retail, specialty multibrand beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.

Share on Social Networks: